Skip to main content
. 2015 Sep 10;6(32):33834–33848. doi: 10.18632/oncotarget.5616

Figure 9. HIF-1α and EWS-FLI-1 levels following Salirasib treatment in vivo.

Figure 9

A. Following treatment with Salirasib for 21 days, the mice were sacrificed and tumors were excised. HIF-1α and EWS-FLI-1 proteins were measured by Western Blot. B. Densitometric illustration of the Western blot. A significant reduction of HIF-1α and EWS-FLI-1 proteins is evident following Salirasib treatment.